Sky Century Investment (SKYI) Return on Assets (2025 - 2026)
Sky Century Investment (SKYI) posted quarterly Return on Assets of 0.01% for Q2 2026, little changed year-over-year from 0.01% in Q2 2025, and up 17.8% quarter-over-quarter from 0.01% in Q1 2026.
Sky Century Investment (SKYI) Return on Assets (2025 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Return on Assets for 2 consecutive years, with 0.01% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through May 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets rose to 0.01% in Q2 2026 per SKYI's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q2 2026 and bottomed at 0.01% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 0.00% |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -0.01% |
| Feb 28, 2026 | -0.01% |
| Nov 30, 2025 | -0.01% |
| Aug 31, 2025 | -0.01% |
| May 31, 2025 | -0.01% |